Diabetes Mellitus Community Based Screening in Minority Populations

• Conditions: Type II Diabetes; Diabetes Mellitus
• Interventions: Behavioral: Education on risk factors for Type II Diabetes; Behavioral: Education on Type II Diabetes; Behavioral: Education on regular visits to a Primary Care Provider

• Registration Number: NCT01591525
• Lead Sponsor: Ethnicity and Disease Community Empowerment Center

Brief Summary

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as help patients without a regular primary care physician (PCP) find one within their community. These goals will be achieved first through a glucose measurement. Individuals with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test. The HgA1c test will tell us about the patients average blood sugar over the past 3 months, which will allow us to immediately diagnose new and uncontrolled type II diabetics. All participants will fill out a survey on healthcare seeking behaviors before glucose testing. All patients who enter the study will receive education on T2D and the value of regularly visiting their PCP, and will be provided a list of PCP currently accepting new patients within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the success this community based screening.

The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.

Detailed Description

Not available

Study Timeline

• Status Verified: 2012-05
• Study First Submitted: 2012-05-02
• Study First Submitted QC: 2012-05-03
• Last Update Submitted: 2012-05-03
• Study First Posted: 2012-05-04
• Last Update Posted: 2012-05-04
• Study Start: 2012-06
• Primary Completion: 2013-01
• Study Completion: 2013-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adults 18 and older

Exclusion Criteria

• Type I Diabetes.
• Women who are currently pregnant.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Newly diagnosised pre-diabetics	Education on risk factors for Type II Diabetes	Individuals who have never been diagnosed with Type II Diabetes, but have a HgA1C of 6.0%-6.9%
Uncontrolled Diabetic	Education on risk factors for Type II Diabetes	Individuals who were previously diagnosed with Type II Diabetes, but have a HgA1C greater than 7.0%
Uncontrolled Diabetic	Education on Type II Diabetes	Individuals who were previously diagnosed with Type II Diabetes, but have a HgA1C greater than 7.0%
Uncontrolled Diabetic	Education on regular visits to a Primary Care Provider	Individuals who were previously diagnosed with Type II Diabetes, but have a HgA1C greater than 7.0%
Newly diagnosed Type II Diabetic	Education on risk factors for Type II Diabetes	Individuals who have never been diagnosed with Type II Diabetes, but have an HgA1c greater than 7.0%
Newly diagnosed Type II Diabetic	Education on Type II Diabetes	Individuals who have never been diagnosed with Type II Diabetes, but have an HgA1c greater than 7.0%
Newly diagnosed Type II Diabetic	Education on regular visits to a Primary Care Provider	Individuals who have never been diagnosed with Type II Diabetes, but have an HgA1c greater than 7.0%
Newly diagnosised pre-diabetics	Education on Type II Diabetes	Individuals who have never been diagnosed with Type II Diabetes, but have a HgA1C of 6.0%-6.9%
Newly diagnosised pre-diabetics	Education on regular visits to a Primary Care Provider	Individuals who have never been diagnosed with Type II Diabetes, but have a HgA1C of 6.0%-6.9%
Controlled	Education on risk factors for Type II Diabetes	Diabetic or non-diabetic individuals with RPCG of less than 130 mg/dl.
Controlled	Education on regular visits to a Primary Care Provider	Diabetic or non-diabetic individuals with RPCG of less than 130 mg/dl.

Trial Locations

Locations (1)

Lower Mills; 🇺🇸 Dorchester, Massachusetts, United States